Brain cancer presents a unique set of challenges for researchers because by the time a person develops symptoms, the tumours are sometimes so complicated that the fundamental mechanisms driving tumour growth are no longer easily identifiable. A research team led by Dr. Peter Dirks is aiming
Washington [US], November 12 (ANI): Scientists at Sanford Burnham Prebys Medical Discovery Institute, University of California San Diego School of Medicine and Hopp Children's Cancer Center Heidelberg (KiTZ) have demonstrated that personalised drug screens can be used to identify new therape